Artivion raises 2025 revenue guidance to $435M-$443M as On-X and stent grafts drive double-digit growth
Source: SeekingAlpha
2025-08-08 14:31:41 ET
More on Artivion
- Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript
- Artivion Non-GAAP EPS of $0.24 beats by $0.11, revenue of $113M beats by $5.05M
- Artivion enter $95M exchange agreement
- Seeking Alpha’s Quant Rating on Artivion
- Historical earnings data for Artivion
Read the full article on Seeking Alpha
For further details see:
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth
Artivion Inc Com
NASDAQ: AORT
AORT Trading
2.11% G/L:
$36.525 Last:
14,272 Volume:
$36 Open:
AORT Latest News
March 03, 2026 04:10:00 pm
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
AORT Stock Data
$1,911,105,039
43,774,444
0.76%
91
N/A
Medical Equipment & Supplies
Healthcare
US
Kennesaw
